Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha

Sanjay Kumar Mahapatra; Subhrasmita Pradhan; Rinu Rani Dash; Bhabagrahi Rath; Siddhartha Goutam; Mousumee Panigrahi

doi:10.5455/njppp.2024.14.11548202318022024

2026, Vol: 16, Issue: 2

16 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Original Research
Online Published: 01 Mar 2024

Natl J Physiol Pharm Pharmacol. 2024; 14(8): 1576-1581

doi: 10.5455/njppp.2024.14.11548202318022024

Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha

Sanjay Kumar Mahapatra, Subhrasmita Pradhan, Rinu Rani Dash, Bhabagrahi Rath, Siddhartha Goutam, Mousumee Panigrahi.

Abstract
Background: Metastatic castration sensitive prostate cancer (mCSPC) has different modalities of management. However, with the arrival of abiraterone acetate (AA), the management of this condition has changed to a greater extent.

Aims and Objectives: As a new molecule its effectiveness and safety are being evaluated in our patient population as a prospective observational study for 18 months.

Materials and Methods: This study included 50 patients who were treated with AA according to the treating physician. The overall survival observed at 18 months was 88%.

Results: There was a significant decrease in mean serum prostate-specific antigen level with treatment. About 60% of patients were completely adhered to the treatment. About 94% of patients experienced some form of adverse event and 10% of patients died in this study. Though the molecule has adverse effects, the overall survival of the patients has increased.

Conclusion: The efficacy of AA was observed consistent with the time in mCSPC patients with manageable adverse events.

Key words: Abiraterone; Metastatic Castration Sensitive Prostate Cancer; Serum Prostate-Specific Antigen Level

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Sanjay Kumar Mahapatra Articles by Subhrasmita Pradhan Articles by Rinu Rani Dash Articles by Bhabagrahi Rath Articles by Siddhartha Goutam Articles by Mousumee Panigrahi
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Mahapatra SK, Pradhan S, Dash RR, Rath B, Goutam S, Panigrahi M. Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha. Natl J Physiol Pharm Pharmacol. 2024; 14(8): 1576-1581.

doi:10.5455/njppp.2024.14.11548202318022024

Web Style

Mahapatra SK, Pradhan S, Dash RR, Rath B, Goutam S, Panigrahi M. Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha. https://www.njppp.com/?mno=177870 [Access: June 27, 2026].

doi:10.5455/njppp.2024.14.11548202318022024

AMA (American Medical Association) Style

Mahapatra SK, Pradhan S, Dash RR, Rath B, Goutam S, Panigrahi M. Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha. Natl J Physiol Pharm Pharmacol. 2024; 14(8): 1576-1581.

doi:10.5455/njppp.2024.14.11548202318022024

Vancouver/ICMJE Style

Mahapatra SK, Pradhan S, Dash RR, Rath B, Goutam S, Panigrahi M. Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha. Natl J Physiol Pharm Pharmacol. (2024), [cited June 27, 2026]; 14(8): 1576-1581.

doi:10.5455/njppp.2024.14.11548202318022024

Harvard Style

Mahapatra, S. K., Pradhan, . S., Dash, . R. R., Rath, . B., Goutam, . S. & Panigrahi, . M. (2024) Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha. Natl J Physiol Pharm Pharmacol, 14 (8), 1576-1581.

doi:10.5455/njppp.2024.14.11548202318022024

Turabian Style

Mahapatra, Sanjay Kumar, Subhrasmita Pradhan, Rinu Rani Dash, Bhabagrahi Rath, Siddhartha Goutam, and Mousumee Panigrahi. 2024. Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha. National Journal of Physiology, Pharmacy and Pharmacology, 14 (8), 1576-1581.

doi:10.5455/njppp.2024.14.11548202318022024

Chicago Style

Mahapatra, Sanjay Kumar, Subhrasmita Pradhan, Rinu Rani Dash, Bhabagrahi Rath, Siddhartha Goutam, and Mousumee Panigrahi. "Effectiveness and safety of abiraterone acetate in metastatic castration-sensitive prostate cancer patients of Western Odisha." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 1576-1581.

doi:10.5455/njppp.2024.14.11548202318022024

MLA (The Modern Language Association) Style

doi:10.5455/njppp.2024.14.11548202318022024

APA (American Psychological Association) Style

doi:10.5455/njppp.2024.14.11548202318022024

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article